ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,887,002 | +145.2% | 830,355 | +92.7% | 0.24% | +114.5% |
| Q1 2023 | $8,109,632 | +25.3% | 430,905 | +8.9% | 0.11% | +22.2% |
| Q3 2022 | $6,471,000 | +76.7% | 395,549 | +52.2% | 0.09% | +60.7% |
| Q2 2022 | $3,663,000 | -62.3% | 259,967 | -37.5% | 0.06% | -59.7% |
| Q4 2021 | $9,714,000 | -0.7% | 416,200 | -29.3% | 0.14% | -13.1% |
| Q3 2021 | $9,781,000 | -39.5% | 588,859 | -11.2% | 0.16% | -47.0% |
| Q2 2021 | $16,172,000 | +60.5% | 663,054 | +69.8% | 0.30% | +34.8% |
| Q1 2021 | $10,077,000 | +270.2% | 390,591 | +667.2% | 0.22% | +211.1% |
| Q4 2020 | $2,722,000 | -79.8% | 50,913 | -84.5% | 0.07% | -83.7% |
| Q3 2020 | $13,506,000 | +352.5% | 327,415 | +431.7% | 0.44% | +275.4% |
| Q2 2020 | $2,985,000 | – | 61,575 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |